The peroxisome proliferator phenylbutyrate reversed the inflammation-induced decrease in ABCD3/PMP70, PEX11β and catalase protein levels and is recommended as a possible drug for treatment of multiple sclerosis [68]. The gene discussed is PEX11B; the disease is multiple sclerosis.